NLM Logo

ALHR88 protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
ALHR88 protocol
Unique ID
C097004
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C097004
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Asparaginase
Cytarabine
Daunorubicin
Methotrexate
Prednisolone
Vincristine
Frequency
2
Note
a chemotherapy protocol with induction therapy consisting of daunorubicin, vincristine, prednisolone, asparaginase; AraC is given to patients greater than or equal 25% blasts in the bone marrow; consolidation therapy is done with intermediate-dose methotrexate
Source
Med Pediatr Oncol 1996 Jan;26(1):10-9
Date of Entry
1996/01/04
Revision Date
2000/11/30
ALHR88 protocol Preferred
page delivered in 0.004s